Foundry Partners LLC Lowers Stock Holdings in Avanos Medical, Inc. (NYSE:AVNS)

Foundry Partners LLC lessened its stake in Avanos Medical, Inc. (NYSE:AVNS) by 26.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 119,870 shares of the company’s stock after selling 43,160 shares during the period. Foundry Partners LLC’s holdings in Avanos Medical were worth $1,908,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Illinois Municipal Retirement Fund increased its holdings in shares of Avanos Medical by 3.1% in the fourth quarter. Illinois Municipal Retirement Fund now owns 25,236 shares of the company’s stock valued at $402,000 after purchasing an additional 748 shares during the period. Quarry LP purchased a new position in Avanos Medical in the 3rd quarter valued at $42,000. Pitcairn Co. increased its stake in Avanos Medical by 13.6% in the 4th quarter. Pitcairn Co. now owns 17,290 shares of the company’s stock valued at $275,000 after buying an additional 2,074 shares during the period. US Bancorp DE raised its position in Avanos Medical by 18.0% during the 4th quarter. US Bancorp DE now owns 14,093 shares of the company’s stock worth $224,000 after buying an additional 2,147 shares during the last quarter. Finally, New York State Teachers Retirement System lifted its stake in shares of Avanos Medical by 4.0% in the 4th quarter. New York State Teachers Retirement System now owns 75,215 shares of the company’s stock worth $1,197,000 after acquiring an additional 2,921 shares during the period. 95.17% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded shares of Avanos Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, March 19th.

Insiders Place Their Bets

In other news, SVP Kerr Holbrook sold 7,000 shares of the business’s stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $15.25, for a total transaction of $106,750.00. Following the sale, the senior vice president now owns 82,047 shares of the company’s stock, valued at $1,251,216.75. The trade was a 7.86 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.64% of the stock is currently owned by company insiders.

Avanos Medical Stock Down 4.4 %

AVNS opened at $13.42 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. Avanos Medical, Inc. has a 12 month low of $13.25 and a 12 month high of $25.36. The stock has a market capitalization of $617.13 million, a P/E ratio of 39.46 and a beta of 1.15. The business has a 50 day simple moving average of $15.48 and a 200-day simple moving average of $18.05.

Avanos Medical (NYSE:AVNS) last released its earnings results on Wednesday, February 26th. The company reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.03. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. The company had revenue of $179.60 million during the quarter, compared to the consensus estimate of $177.23 million. On average, equities analysts anticipate that Avanos Medical, Inc. will post 1.32 earnings per share for the current fiscal year.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.